Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apollon Formularies
London, England, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Apollon Formularies develops and sells pharmaceutical and nutraceutical medical cannabis products (including 3D‑printed sublingual, suppository and capsule formulations) for cancer and other conditions, and has reported in vitro cancer cell‑killing results with its cannabis and medicinal mushroom formulations, but no registered conventional clinical trial outcomes were identified in public sources.
- Therapeutic areas
- ImmunologyNeurologyGastroenterologyMetabolic DisordersOncology
- Modalities
- Small moleculePlant-derived extract
- Industry
- Biotech
Beyond the preview
Go deeper on Apollon Formularies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Apollon Formularies.